Four of the leukemia samples were derived from infants below one year of age and characterized by a pro-B ALL immunophenotype and either MLL/AF4 (N = 1) or MLL/ENL (N = 3) gene fusions. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.